» Articles » PMID: 21082229

Finnish Prenatal Study of Autism and Autism Spectrum Disorders (FIPS-A): Overview and Design

Abstract

This article presents an overview of the Finnish Prenatal Study of Autism and Autism Spectrum Disorders (FIPS-A), a new study designed to examine the relationship between prenatal serologic factors, mediating and moderating developmental antecedents, and risk of autism spectrum disorders (ASD). The FIPS-A is based on register linkages between births from 1987 to 2005 ascertained from the Finnish Medical Birth Register (FMBR) and other national registers on treatment for this group of disorders. All subjects were members of the Finnish Maternity Cohort (FMC), which consists of virtually all births in Finland from 1983 to the present, and which includes archived maternal serum samples. This study also capitalizes on other registry information, such as systematically collected data on pregnancy, prenatal and neonatal complications and manual data collection from well-child clinics providing developmental data from birth to the age of 7 years. In this paper, we describe the methods used in the FIPS-A study, including a description of the national registers, available data and case ascertainment procedures. Finally, we discuss implications of the data for future work on uncovering putative aetiologies of ASD and key strengths and limitations of the design.

Citing Articles

Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis.

Mazon-Cabrera R, Liesenborgs J, Brone B, Vandormael P, Somers V Front Neurosci. 2023; 17:1067833.

PMID: 36816132 PMC: 9932693. DOI: 10.3389/fnins.2023.1067833.


Maternal serum persistent organic pollutant exposure and offspring diagnosed ADHD in a national birth cohort.

Cheslack-Postava K, Rantakokko P, Kiviranta H, Hinkka-Yli-Salomaki S, Surcel H, Vivio N Environ Res. 2022; 212(Pt A):113145.

PMID: 35318010 PMC: 9232966. DOI: 10.1016/j.envres.2022.113145.


Time trends in treated incidence, sociodemographic risk factors and comorbidities: a Finnish nationwide study on anxiety disorders.

Khanal P, Stahlberg T, Luntamo T, Gyllenberg D, Kronstrom K, Suominen A BMC Psychiatry. 2022; 22(1):144.

PMID: 35193518 PMC: 8864838. DOI: 10.1186/s12888-022-03743-3.


A biomarker-based study of prenatal smoking exposure and autism in a Finnish national birth cohort.

Cheslack-Postava K, Sourander A, Hinkka-Yli-Salomaki S, McKeague I, Surcel H, Brown A Autism Res. 2021; 14(11):2444-2453.

PMID: 34505741 PMC: 10339819. DOI: 10.1002/aur.2608.


Risk for Premature Mortality and Intentional Self-harm in Autism Spectrum Disorders.

Jokiranta-Olkoniemi E, Gyllenberg D, Sucksdorff D, Suominen A, Kronstrom K, Chudal R J Autism Dev Disord. 2020; 51(9):3098-3108.

PMID: 33140146 PMC: 8349316. DOI: 10.1007/s10803-020-04768-x.


References
1.
Gissler M, Shelley J . Quality of data on subsequent events in a routine Medical Birth Register. Med Inform Internet Med. 2003; 27(1):33-8. DOI: 10.1080/14639230110119234. View

2.
Kolevzon A, Gross R, Reichenberg A . Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med. 2007; 161(4):326-33. DOI: 10.1001/archpedi.161.4.326. View

3.
Lampi K, Sourander A, Gissler M, Niemela S, Rehnstrom K, Pulkkinen E . Brief report: validity of Finnish registry-based diagnoses of autism with the ADI-R. Acta Paediatr. 2010; 99(9):1425-8. DOI: 10.1111/j.1651-2227.2010.01835.x. View

4.
Parner E, Schendel D, Thorsen P . Autism prevalence trends over time in Denmark: changes in prevalence and age at diagnosis. Arch Pediatr Adolesc Med. 2008; 162(12):1150-6. DOI: 10.1001/archpedi.162.12.1150. View

5.
Teperi J . Multi method approach to the assessment of data quality in the Finnish Medical Birth Registry. J Epidemiol Community Health. 1993; 47(3):242-7. PMC: 1059775. DOI: 10.1136/jech.47.3.242. View